, 2010 and Ullsperger and von Cramon, 2003), nucleus accumbens (N

, 2010 and Ullsperger and von Cramon, 2003), nucleus accumbens (NAcc) (Seymour et al., 2007), and amygdala (Breiter et al., 2001 and Yacubian et al., 2006). (These analyses were intended to bring greater statistical power to bear on these regions, in part because their small size may have undermined our ability to detect activation in them in our whole-brain analysis, where a cluster-size

threshold was employed.) The habenular complex was found to display greater activity following type D than type E jumps (p < 0.05), consistent with the idea that this structure is also engaged by negative PPEs. A comparable effect was also observed in the right, though not left, amygdala (p < 0.05). In the NAcc, where some studies have observed deactivation accompanying negative RPEs (Knutson et al., 2005), no significant PPE effect was observed. Hydroxychloroquine cell line However, it should be noted that NAcc deactivation with negative RPEs has been an inconsistent finding in previous work (for example, see Cooper and Knutson, 2008 and O’Doherty et al., 2006). More robust is the association between

NAcc activation and positive RPEs (Hare et al., 2008, Niv, 2009 and Seymour Ulixertinib manufacturer et al., 2004). To test this directly, we ran a second, smaller fMRI study designed to elicit positive PPEs, specifically looking for activation within a NAcc ROI. A total of 14 participants performed the delivery task, with jumps of type C (in Figure 2) occurring on one-third of trials and jumps of type E on another third. As described earlier, a positive PPE is predicted to occur in association with type C jumps, and in this setting significant activation (p < 0.05) was observed in the right (though not left) NAcc, scaling with predicted PPE magnitude. We have characterized the results from our EEG and fMRI experiments as displaying a “signature” of HRL, in the sense that the PPE signal is predicted by HRL but not by standard RL algorithms (Figure 2). However, there

is an important caveat that we now consider. In our neuroimaging experiments we assumed that reaching the goal (the house) would be associated with primary reward. (The same points hold if “primary reward” is replaced Rebamipide with “secondary” or “conditioned reinforcement.”) We also assumed that reaching the subgoal (the package) was not associated with primary reward but only with pseudo-reward. However, what if participants did attach primary reward to the subgoal? If this were the case, it would present a difficulty for the interpretation of our neuroimaging results because it would lead standard RL to predict an RPE in association with events that change only subgoal distance (including C and D jumps in our neuroimaging task). In view of these points, it was necessary to establish whether participants performing the delivery task did or did not attach primary reward to subgoal attainment. In order to evaluate this, we devised a modified version of the task.

Comments are closed.